Clinical implications and cost-effectiveness analysis of rivaroxaban in patients with coronary artery disease or peripheral arterial disease in the Netherlands
| Verfasser: | |
|---|---|
| Dokumenttyp: | Artikel |
| Erscheinungsdatum: | 2021 |
| Reihe/Periodikum: | Journal of Medical Economics ; volume 24, issue 1, page 1231-1239 ; ISSN 1369-6998 1941-837X |
| Verlag/Hrsg.: |
Informa UK Limited
|
| Schlagwörter: | Health Policy |
| Sprache: | Englisch |
| Permalink: | https://search.fid-benelux.de/Record/base-26819083 |
| Datenquelle: | BASE; Originalkatalog |
| Powered By: | BASE |
| Link(s) : | http://dx.doi.org/10.1080/13696998.2021.1997024 |
